Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
1967MO Preliminary efficacy and safety of disitamab vedotin (DV) with pembrolizumab (P) in treatment (Tx)-naive HER2-expressing, locally advanced or metastatic urothelial carcinoma (la/mUC): RC48G001 cohort C
Matthew D. Galsky, Vadim S. Koshkin, Matthew T. Campbell, Alexandra Drakaki, Isaac Alex Bowman, April A. N. Rose and 11 more
- Rank
- 82 of 3,853
- Percentile
- top 2.2%
- Where
- Annals of Oncology, 2024
- Citations
- 30
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.